Carrier-Linked Prodrugs Having Reversible Carboxylic Ester Linkages

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140249093A1
SERIAL NO

14238447

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a carrier-linked prodrugs, wherein the biologically active moieties comprise at least one carboxylic acid and wherein the linkage between the drug moiety and linker is in the form of an ester wherein the hydroxyl group required for ester formation is provided by the linker moiety and the carboxyl group required for ester formation is provided by the drug moiety. The hydroxyl group of the linker is sterically hindered by the presence of an alkyl or aryl group on the carbon directly bound to or adjacent to the carbon carrying the hydroxyl group (α-carbon). The steric effect of the alkyl or aryl group enables greater control of the rate of hydrolytic degradation of such carrier-linked prodrugs.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASCENDIS PHARMA A/S2900 HELLERUP

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Rau, Harald Dossenheim, DE 112 1733
Vetter, Dirk Heidelberg, DE 51 1592

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation